ESR1 and breast cancer: Triple-negative breast cancer (TNBC), accounting for 15% incidence among all types of BC, is characterized by radical loss of progesterone receptors and estrogen receptors expression as well as absence of overexpression of amplification of the human epidermal growth factor receptor-2, the 3 typical biomarkers for BC [1].